Schrödinger Shares Slide 11.6% as Rally Reverses Without a Fresh Catalyst

2026-10-06

Investivoq PriceTracker

Schrödinger (SDGR) is down 11.6% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely explanation is a sharp pullback after a recent run-up, with no new company announcement or major SEC current report visible to support the stock at these levels. This could also be because investors are digesting earlier bullish updates while reacting cautiously to insider-sale paperwork and the stock’s already elevated volatility.

Details:

Schrödinger’s investor materials show its last major business updates were in August and September, including second-quarter results, an AI software collaboration, and a licensing deal tied to a newly formed biotech company, rather than a fresh October catalyst.

In its August quarterly release, the company raised its 2026 drug discovery revenue outlook, posted second-quarter revenue growth, and ended the quarter with more than $400 million in cash and marketable securities.

SEC records show a Form 144 was filed on September 17, 2026, signaling a proposed sale of shares by an insider or affiliate; those filings do not prove selling occurred, but they can weigh on sentiment in a fast-moving stock.

The shares were also highly volatile in recent sessions, including a strong gain on October 5, which makes today’s drop look consistent with profit-taking and a reversal in speculative momentum.

Sources:

Schrödinger Investor Relations, SEC, Stock Analysis

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$SDGR Insider Trading Activity

$SDGR insiders have traded $SDGR stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $SDGR stock by insiders over the last 6 months:

RAMY FARID (President & CEO) has made 0 purchases and 2 sales selling 86,000 shares for an estimated $1,055,177.
KAREN AKINSANYA (See Remarks) has made 0 purchases and 2 sales selling 31,599 shares for an estimated $927,970.
RACHIT JAIN (EVP & CFO) has made 0 purchases and 2 sales selling 1,719 shares for an estimated $24,405.

To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

$SDGR Hedge Fund Activity

We have seen 114 institutional investors add shares of $SDGR stock to their portfolio, and 99 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

LAZARD ASSET MANAGEMENT LLC removed 1,904,015 shares (-89.2%) from their portfolio in Q2 2026, for an estimated $30,940,243
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 1,817,750 shares (-67.7%) from their portfolio in Q2 2026, for an estimated $29,538,437
AQR CAPITAL MANAGEMENT LLC added 1,512,189 shares (+340.5%) to their portfolio in Q2 2026, for an estimated $24,573,071
BLACKROCK, INC. added 843,164 shares (+8.7%) to their portfolio in Q2 2026, for an estimated $13,701,415
BAILLIE GIFFORD & CO removed 835,488 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $13,576,680
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 586,766 shares (+inf%) to their portfolio in Q2 2026, for an estimated $9,534,947
JACOBS LEVY EQUITY MANAGEMENT, INC added 523,675 shares (+inf%) to their portfolio in Q2 2026, for an estimated $8,509,718

To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.